Potassium adjusted for pH in DKA focuses on the ability of pH-adjusted potassium to predict the timing and severity of hypokalemia in patients with diabetic ketoacidosis (DKA) during their treatment. The study proposes that the use of pH-adjusted potassium as a marker for hypokalemia could significantly improve both clinical outcomes and patient health by allowing a more appropriate initiation of potassium replacement. The main focus is the analysis of the impact of pH-adjusted potassium on the development of hypokalemia in patients with Diabetic Ketoacidosis (DKA) at the National Hospital of Loreto between 2021 and 2022. The aim is to evaluate the utility of serum potassium adjusted in the clinical management of hypokalemia, a common electrolyte disorder in patients with DKA. The methodology includes an observational, analytical, cross sectional, and retrospective study with a retrospec...